Retirement Systems of Alabama cut its stake in Cabot Corporation (NYSE:CBT – Free Report) by 16.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 53,390 shares of the specialty chemicals company’s stock after selling 10,631 shares during the quarter. Retirement Systems of Alabama’s holdings in Cabot were worth $4,849,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently modified their holdings of CBT. Fuller & Thaler Asset Management Inc. boosted its position in shares of Cabot by 5.6% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 2,343,322 shares of the specialty chemicals company’s stock worth $155,315,000 after buying an additional 124,613 shares during the period. State Street Corp grew its stake in shares of Cabot by 1.0% in the fourth quarter. State Street Corp now owns 2,025,589 shares of the specialty chemicals company’s stock valued at $134,256,000 after buying an additional 20,021 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Cabot by 4.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,742,782 shares of the specialty chemicals company’s stock valued at $131,253,000 after buying an additional 79,499 shares during the period. Bank of America Corp DE lifted its position in Cabot by 3.9% during the 3rd quarter. Bank of America Corp DE now owns 1,683,520 shares of the specialty chemicals company’s stock worth $128,032,000 after acquiring an additional 63,080 shares in the last quarter. Finally, Sei Investments Co. lifted its position in Cabot by 6.5% during the 1st quarter. Sei Investments Co. now owns 1,051,578 shares of the specialty chemicals company’s stock worth $79,194,000 after acquiring an additional 64,122 shares in the last quarter. Institutional investors and hedge funds own 93.18% of the company’s stock.
Wall Street Analysts Forecast Growth
CBT has been the subject of several recent research reports. Wall Street Zen raised shares of Cabot from a “hold” rating to a “buy” rating in a research report on Sunday, August 9th. UBS Group reduced their target price on shares of Cabot from $97.00 to $92.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 5th. JPMorgan Chase & Co. upped their target price on shares of Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a research note on Friday, August 7th. Truist Financial set a $100.00 price target on shares of Cabot in a report on Wednesday, August 5th. Finally, Mizuho lifted their price target on shares of Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a research note on Thursday, June 25th. Two analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Cabot presently has a consensus rating of “Hold” and an average target price of $89.00.
Cabot Trading Down 0.0%
Shares of CBT opened at $86.28 on Friday. The company has a market capitalization of $4.45 billion, a P/E ratio of 24.30, a P/E/G ratio of 11.26 and a beta of 0.84. Cabot Corporation has a one year low of $58.33 and a one year high of $94.53. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.97 and a current ratio of 1.47. The stock has a 50-day moving average price of $87.98 and a 200 day moving average price of $80.34.
Cabot (NYSE:CBT – Get Free Report) last posted its quarterly earnings data on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.66 by $0.01. Cabot had a return on equity of 20.29% and a net margin of 5.23%.The company had revenue of $982.00 million for the quarter, compared to the consensus estimate of $943.16 million. During the same period in the previous year, the business earned $1.90 EPS. Cabot’s revenue for the quarter was up 6.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Sell-side analysts forecast that Cabot Corporation will post 6.33 EPS for the current fiscal year.
Cabot Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 28th will be given a dividend of $0.4725 per share. The ex-dividend date of this dividend is Friday, August 28th. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.2%. Cabot’s dividend payout ratio (DPR) is presently 53.24%.
Insider Activity
In related news, CEO Sean D. Keohane sold 91,923 shares of Cabot stock in a transaction on Friday, August 7th. The shares were sold at an average price of $86.41, for a total value of $7,943,066.43. Following the completion of the sale, the chief executive officer owned 404,134 shares in the company, valued at approximately $34,921,218.94. The trade was a 18.53% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 3.08% of the company’s stock.
Cabot Company Profile
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
Read More
- Five stocks we like better than Cabot
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT – Free Report).
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
